Publications by authors named "Thomas Slavin"

Claim this Profile
A
Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two Cases.
Georges Azzi, Thomas P Slavin, Jesus Izaguirre-Carbonell, Hillary S Sloane, Daniel L Edelstein

Case Rep Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
Lauren Lenz, Wyatt Clegg, Diana Iliev, Chelsea R Kasten, Howard Korman, Thomas P Slavin

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.
Marcy E Richardson, Megan Holdren, Terra Brannan, Miguel de la Hoya, Amanda B Spurdle, Thomas Slavin

Am J Hum Genet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.
Tuya Pal, Erin Mundt, Marcy E Richardson, Elizabeth Chao, Tina Pesaran, Thomas P Slavin

NPJ Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors.
Brent Mabey, Elisha Hughes, Matthew Kucera, Timothy Simmons, Brooke Hullinger, Thomas P Slavin

Genet Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline sequence variants.
Marcy E Richardson, Megan Holdren, Terra Brannan, Miguel de la Hoya, Amanda B Spurdle, Thomas Slavin

medRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Lauren Lenz, Chris Neff, Cara Solimeno, Elizabeth S Cogan, Vandana G Abramson, Thomas P Slavin

Breast Cancer Res Treat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants.
Erin Mundt, Brent Mabey, Irene Rainville, Charite Ricker, Nanda Singh, Thomas Slavin

Cancer Genet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing.
Melanie A Jones, Kirsten M Timms, Shanell Hatcher, Elizabeth S Cogan, Matthew S Comeaux, Thomas P Slavin

Genes Chromosomes Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Genetic Testing After Cancer Diagnosis.
Allison W Kurian, Paul Abrahamse, Allison Furgal, Kevin C Ward, Ann S Hamilton, Thomas P Slavin

JAMA· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between age at breast cancer diagnosis and prevalence of pathogenic variants.
Mary B Daly, Eric Rosenthal, Shelly Cummings, Ryan Bernhisel, John Kidd, Thomas P Slavin

Breast Cancer Res Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma.
Elizabeth A Bloom, Pamela N Peters, Regina Whitaker, Shonagh Russell, Benjamin Albright, Thomas Slavin

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First estimates of diffuse gastric cancer risks for carriers of germline pathogenic variants.
Marie Coudert, Youenn Drouet, Hélène Delhomelle, Magali Svrcek, Patrick R Benusiglio, Thomas Slavin

J Med Genet· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
Elisha Hughes, Susanne Wagner, Dmitry Pruss, Ryan Bernhisel, Braden Probst, Thomas P Slavin

JCO Precis Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.
Bita Nehoray, Thomas P Slavin, Can-Lan Sun, Karen Hurley, Elisabeth King

J Genet Couns· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer.
Anastasia Constantinidou, Yiola Marcou, Michael S Toss, Timothy Simmons, Ryan Bernhisel, Thomas P Slavin

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status.
Danielle Castillo, Tze-An Yuan, Bita Nehoray, Aleck Cervantes, Kevin K Tsang, Thomas P Slavin

Cancer Epidemiol Biomarkers Prev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Neal D Shore, Lauren Lenz, Elizabeth S Cogan, Diana Iliev, Lizzie Spencer, Thomas P Slavin

Prostate· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.
Allison W Kurian, Paul Abrahamse, Kevin C Ward, Ann S Hamilton, Dennis Deapen, Thomas Slavin

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Allison W Kurian, Elisha Hughes, Timothy Simmons, Ryan Bernhisel, Braden Probst, Thomas P Slavin

Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond descriptive statistics: using additional analyses to determine the technological feasibility of meeting a new exposure limit.
Benjamin Roberts, Taylor Tarpey, Nicole Zoghby, Thomas Slavin

J Occup Environ Hyg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multigene assessment of genetic risk for women for two or more breast cancers.
Jeffrey N Weitzel, John Kidd, Ryan Bernhisel, Susan Shehayeb, Paul Frankel, Thomas P Slavin

Breast Cancer Res Treat· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations and age at onset of lung adenocarcinoma.
Karen L Reckamp, Carolyn E Behrendt, Thomas P Slavin, Stacy W Gray, Danielle K Castillo

Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Breast Cancer Risk Assessment for and Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model.
Shannon Gallagher, Elisha Hughes, Allison W Kurian, Susan M Domchek, Judy Garber, Thomas P Slavin

JCO Precis Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
Cristina Fortuno, Kristy Lee, Magali Olivier, Tina Pesaran, Phuong L Mai, Thomas P Slavin

Hum Mutat· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis